Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Salinas, CA
NPI: 1295732410Primary Employer
Salinas Valley Health Clinics
salinasvalleyhealth.com
HQ Phone
Get M.D. Shehzad's Phone Numberphone_androidMobile
Get M.D. Shehzad's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
NJ State Medical License
1994
CA State Medical License
1998 - 2025
Boston University Medical Center
Fellowship • Hematology and Medical Oncology
1995 - 1998
Hackensack University Medical Center/Englewood Hospital and Medical Center
Residency • Internal Medicine
1991 - 1995
Rawalpindi Medical College
Medical School
Until 1983
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 287 | 451 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 244 | 805 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 64 | 238 |
| 4 | 99203New patient outpatient visit, total time 30-44 minutes | 56 | 56 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 35 | 35 |
Lead Sponsor: NRG Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Docetaxel, DRUG: Pembrolizumab, DRUG: Gemcitabine, DRUG: Pemetrexed Disodium, DRUG: Erlotinib Hydrochloride, RADIATION: Stereotactic Body Radiation Therapy (SBRT), RADIATION: Intensity-Modulated Radiation Therapy (IMRT), RADIATION: 3-Dimensional Conformal Radiation Therapy (3D-CRT)
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Quality-of-Life Assessment, DRUG: Fluorouracil, DRUG: Bevacizumab, DRUG: Oxaliplatin, DRUG: Irinotecan, DIETARY_SUPPLEMENT: Cholecalciferol, DRUG: Irinotecan Hydrochloride, DRUG: Leucovorin Calcium
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Cisplatin, DRUG: Gemcitabine Hydrochloride, DRUG: Nab-paclitaxel